- Home
- BTBT vs COGT Comparison
BTBT vs COGT Comparison
Compare BTBT & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTBT
- COGT
- Stock Information
- Founded
- BTBT 2015
- COGT 2014
- Country
- BTBT United States
- COGT United States
- Employees
- BTBT N/A
- COGT N/A
- Industry
- BTBT Finance: Consumer Services
- COGT Biotechnology: Pharmaceutical Preparations
- Sector
- BTBT Finance
- COGT Health Care
- Exchange
- BTBT Nasdaq
- COGT Nasdaq
- Market Cap
- BTBT 1.1B
- COGT 1.1B
- IPO Year
- BTBT 2018
- COGT 2018
- Fundamental
- Price
- BTBT $2.99
- COGT $10.96
- Analyst Decision
- BTBT Strong Buy
- COGT Strong Buy
- Analyst Count
- BTBT 3
- COGT 9
- Target Price
- BTBT $6.33
- COGT $20.25
- AVG Volume (30 Days)
- BTBT 46.6M
- COGT 2.3M
- Earning Date
- BTBT 08-18-2025
- COGT 08-05-2025
- Dividend Yield
- BTBT N/A
- COGT N/A
- EPS Growth
- BTBT N/A
- COGT N/A
- EPS
- BTBT N/A
- COGT N/A
- Revenue
- BTBT $102,037,923.00
- COGT N/A
- Revenue This Year
- BTBT $20.87
- COGT N/A
- Revenue Next Year
- BTBT $38.28
- COGT N/A
- P/E Ratio
- BTBT N/A
- COGT N/A
- Revenue Growth
- BTBT 52.44
- COGT N/A
- 52 Week Low
- BTBT $1.69
- COGT $3.72
- 52 Week High
- BTBT $5.74
- COGT $12.97
- Technical
- Relative Strength Index (RSI)
- BTBT 48.44
- COGT 52.79
- Support Level
- BTBT $2.66
- COGT $10.38
- Resistance Level
- BTBT $3.64
- COGT $12.07
- Average True Range (ATR)
- BTBT 0.28
- COGT 0.56
- MACD
- BTBT -0.04
- COGT -0.32
- Stochastic Oscillator
- BTBT 33.67
- COGT 24.07
About BTBT Bit Digital Inc.
Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.